CGTX - Company ID 0001455365
The table below shows COGNITION THERAPEUTICS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$24.59M | -$28.47M | -$16.02M | -$18.53M | -$3.63M | -$3.43M |
| Capital expenditure | - | $4.00K | $147.00K | $171.00K | $27.00K | $10.00K |
| Investing cash flow | $9.00K | -$4.00K | -$147.00K | -$171.00K | -$27.00K | -$10.00K |
| Dividends paid | - | - | - | - |
COGNITION THERAPEUTICS INC reported operating cash flow of -$24.59M for fiscal year 2025. That is up 13.6% from -$28.47M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$3.43M (FY 2020) to -$24.59M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $36.57M | $23.57M | $4.52M | $5.55M | $53.20M | $5.76M |